ST
NVAX icon

Spot Trading’s Novavax NVAX Stock Holding History

Spot Trading’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-500
Closed -$13K – 3205
2016
Q4 		$13K Sell
500
-115
-19% -$3.35K ﹤0.01% 2604
2016
Q3 		$26K Buy
615
+510
+486% +$65.8K ﹤0.01% 2777
2016
Q2 		$15K Buy
+105
New +$12K ﹤0.01% 3026
2016
Q1 		– Sell
-1,500
Closed -$252K – 3796
2015
Q4 		$252K Hold
1,500
– – ﹤0.01% 2342
2015
Q3 		$212K Buy
1,500
+1,475
+5,900% +$331K ﹤0.01% 2660
2015
Q2 		$6K Sell
25
-65
-72% -$11.4K ﹤0.01% 3628
2015
Q1 		$15K Sell
90
-10,000
-99% -$1.62M ﹤0.01% 3532
2014
Q4 		$1.2M Sell
10,090
-24,695
-71% -$2.58M 0.01% 1769
2014
Q3 		$2.9M Buy
34,785
+34,590
+17,738% +$3.13M 0.01% 1285
2014
Q2 		$18K Buy
195
+145
+290% +$12.7K ﹤0.01% 4189
2014
Q1 		$5K Sell
50
-2,200
-98% -$246K ﹤0.01% 4009
2013
Q4 		$230K Buy
+2,250
New +$159K ﹤0.01% 2944

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spot Trading's NVAX Position: Q1 2017 in Review

Spot Trading sold out of Novavax (NVAX) in Q1 2017, closing a stake of 498 shares — an estimated $13K sold.

Spot Trading first reported a position in NVAX in Q4 2013 and held it in 11 quarters. The position peaked at $1.03M in Q3 2014. 129 funds tracked by Wall St. Rank hold NVAX as of Q1 2017.

  • Spot Trading reported no remaining Novavax position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 498 Novavax shares in Q1 2017, an estimated $13K.
  • Spot Trading first reported a position in Novavax in Q4 2013 and held it in 11 quarters.
  • Spot Trading's Novavax position peaked at $1.03M in Q3 2014.
  • 129 funds tracked by Wall St. Rank held Novavax as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.